Latest News - Waters Corporation

Top Corporates Hub

Waters Corporation

WAT | NYSE | United States
738
+256
Rank
$17.05B
Market Cap
$2.95B
Revenue
$0.84B
+$ 0.22B
+35.48%
Earnings
7.6K
-0.3K
-3.8%
Employees
Waters (WAT) Stock Looks 26% Overvalued On Cash Flow Estimates

21.10.2026 04:31

Waters Corporation has logged a powerful run in recent years, and the stock now sits at a level where investors naturally ask whether the current price is in line with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available, the question is how that cash flow based estimate stacks up against a share price that has already moved a long way. Over the past 3 years Waters has returned 77.7%, which puts real weight on getting the cash flow valuation call...

Read More

Earnings Preview: What to Expect From Waters Corporation’s Report

19.10.2026 13:29

Waters Corporation is all geared up to release its third-quarter earnings next month, and analysts anticipate a double-digit boost in its profitability.

Read More

IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease

19.10.2026 07:08

LONDON, October 19, 2026--IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company using its High Definition Immunology™ platform to better understand the immune system and drive a shift in how we understand, diagnose, and treat disease, has today announced a new collaboration with UK Biobank to generate large-scale multi-omic immune profiling data from 80,000 blood samples collected from UK Biobank participants.

Read More

Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation

19.10.2026 07:05

Ultima Genomics, Inc., developer of ultra-high-throughput next-generation sequencing (NGS) platforms, today announced that its recently launched UG200 Sequencing Platform has been selected to power a new large-scale immune profiling study with IMU Biosciences and UK Biobank. The study will generate one of the most detailed pictures of the human immune system assembled to date, adding a high-resolution immune data layer and a foundational dataset for AI to UK Biobank, one of the world's most impo

Read More

Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

13.10.2026 12:00

Waters Corporation (NYSE: WAT) today announced that it has launched Waters AI Link, a software capability that brings Anthropic's Model Context Protocol (MCP) to its informatics platform and has joined Anthropic's Model Hardware Standard (MHS) research program.

Read More

Here's Why You Should Retain WAT Stock in Your Portfolio for Now

08.10.2026 13:10

Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.

Read More

CellCarta, Waters Corporation collaborate on companion diagnostics

06.10.2026 10:28

Under the framework, the two organisations will initially focus on flow cytometry-based programmes.

Read More

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

01.10.2026 13:00

Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 1, 2026, at midnight Eastern Time.

Read More

Guggenheim Maintains Buy on Waters, Raises Price Target to $490

01.10.2026 09:47

Guggenheim analyst Subbu Nambi maintains Waters (NYSE:WAT) with a Buy and raises the price target from $440 to $490.

Read More

1 Volatile Stock with Promising Prospects and 2 We Avoid

30.09.2026 10:05

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Read More

1 Volatile Stock with Promising Prospects and 2 We Avoid

30.09.2026 10:05

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Read More

1 Growth Stock with All-Star Potential and 2 We Find Risky

24.09.2026 11:20

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Read More

Robust Results Lifted Waters (WAT)

23.09.2026 12:43

Madison Investments, an investment advisor, released its second-quarter 2026 investor letter for the “Madison Mid Cap Fund”. You can download a copy of the letter here. U.S. stock market indices posted their strongest second-quarter performance since 2020, driven largely by enthusiasm for Artificial Intelligence. Nine of the ten largest companies in the Russell Midcap Index […]

Read More

Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript

23.09.2026 10:19

Waters Corporation (WAT) U.S. All Stars Conference September 23, 2026 7:00 AM EDTCompany ParticipantsUdit Batra - President, CEO & DirectorConference...

Read More

Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday

21.09.2026 09:03

Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.

Read More

Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515

21.09.2026 07:09

Goldman Sachs analyst Evie Koslosky maintains Waters (NYSE:WAT) with a Buy and raises the price target from $465 to $515.

Read More

3 Large-Cap Stocks for Long-Term Investors

18.09.2026 09:13

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

Read More

Waters (WAT) Stock Could Be A Bargain On Cash Flow Yet Fully Priced On Sales

04.09.2026 12:11

Waters stock has put in a strong multi year gain, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside while the earnings multiple checks lean expensive. Over the past 3 years, Waters has returned about 53%, which puts more pressure on today’s entry price to be well supported by fundamentals. The company’s ability to keep converting its specialized analytical instruments and services into steady cash flow can...

Read More

Waters (WAT) Raised Guidance, Is The Stock Still Cheap?

04.09.2026 03:09

Waters (WAT) stock is back in focus after the company reported Q2 2026 adjusted earnings of $3.05 per share and raised its full year guidance for organic revenue growth and adjusted earnings. At a share price of $413.56, Waters has posted a 30 day share price return of 4.41% and a 90 day share price return of 13.19%. The 1 year total shareholder return of 38% and 3 year total shareholder return of 53% point to building momentum supported by upgraded guidance and recent leadership...

Read More

Leadership Shift And Upgraded Outlook Could Be A Game Changer For Waters (WAT)

04.09.2026 00:20

Waters Corporation recently announced that Senior Vice President of the Waters Analytical Sciences Division, Robert L. Carpio III, resigned in August 2026, with Tina Wu, previously head of the Materials Sciences Division and President, China, stepping into the role after more than two decades of global leadership experience at DuPont. Around the same time, Waters reported very large year-over-year revenue growth in the second quarter of 2026 and raised its full-year guidance, underlining the...

Read More